Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
BTAIQ	BioXcel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$642.0K	-$69.90M	n/m	n/a	-71.7%	-$5.73
BYSI	BeyondSpring Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.01M	n/a	n/a	n/a	n/a
CALC	CalciMedica, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.56M	n/a	n/a	n/a	-$1.97
CASIF	CASI Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.71M	-$48.06M	-232.0%	n/a	-27.4%	-$2.59
CDT	CDT Equity Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$1177.89
CELU	Celularity Inc Manufacturing · Year ended 2025-12-31 · USD	$26.55M	-$91.72M	-345.4%	n/a	-51.0%	-$3.59
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
CMPS	COMPASS Pathways plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$287.86M	n/a	n/a	n/a	-$3.08
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
CYDY	CytoDyn Inc. Manufacturing · Year ended 2026-05-31 · USD	n/a	-$42.70M	n/a	n/a	n/a	-$0.03
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
ELTX	Elicio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.57M	n/a	n/m	n/a	-$2.58
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80
EVFM	Evofem Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.18M	$391.0K	1.9%	n/a	4.2%	$0.00
FHTX	Foghorn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$74.28M	-240.3%	n/a	36.8%	-$1.18
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00
GLSI	Greenwich LifeSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.36M	n/a	n/m	n/a	-$1.43
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
IMUX	Immunic, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$97.17M	n/a	n/a	n/a	-$0.62
INDV	Indivior Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.24B	$210.00M	16.9%	n/a	4.3%	$1.64
INM	InMed Pharmaceuticals Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$12.56M	n/a	n/m	n/a	-$3.12
INTI	Inhibitor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.30M	n/a	n/a	n/a	-$0.02

Rows per page: 2550 100